Texas has run out of its supply of monoclonal antibodies, and infusion centers in the state will be unable to offer the treatment for Omicron until January.
Infusion centers in Austin, El Paso, Fort Worth, San Antonio and The Woodlands have all gone through their supply of sotrovimab, the only antibody treatment believed to be effective against the omicron variant, the Texas Health and Human Services Commission said.
The agency said infusion centers in Texas will be unable to offer the treatment until “federal authorities ship additional courses of sotrovimab to Texas in January.”
“Other monoclonal antibodies have not shown to be effective against the Omicron variant, which now accounts for more than 90% of new cases. The infusion centers will continue to offer those antibodies as prescribed by health care providers for people diagnosed with a non-Omicron case of COVID-19,” the Texas commission said.
However, the CDC announced on Tuesday (Dec 28) that only 58.6% of COVID-19 cases are Omicron.